AI-generated summary
In a split-face trial of 28 patients with melasma, the authors compared low-fluence Q-switched 1064-nm laser alone with the same laser combined with microsecond pulse mode. Of the 28 enrolled, 21 completed follow-up, and the authors report improved melasma scores at 1 and 3 months, with less melanin increase at later follow-up on the combined-treatment side and no reported adverse events.
- Participants
- 28
- Who or what was studied
- Patients with melasma enrolled in a single-center split-face trial; 21 of 28 completed all treatments and follow-ups
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- Small, single-center, evaluator-blinded study with a relatively small number of completers and no long-term follow-up beyond 12 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on nature.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Fluence, Laser, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.